New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
Highly Regulated (List I)

OXACARE

1G/FL. DE PDRE./Powder + Solvent for Injectable Sol./IV/OXACILLINE SODIQUE EXPRIME EN OXACILLINE
BIOCARE
ManufacturerVerified lab

BIOCARE

Public retail price
897.52DZD
Reference price (TR): 500.00 DZD

Identification

Active ingredient (INN)
OXACILLINE SODIQUE EXPRIME EN OXACILLINE
Internal code
13 G 069
Country of Origin
Algeria
Pharmaceutical form
Powder + Solvent for Injectable Sol./IV
Prescription List
Highly Regulated (List I)
Packaging
b/01fl. de pdre. + 01amp. de 5ml de solv. (eppi) et b/50fl. de pdre.
OXACARE
Clinical View
Highly Regulated (List I)

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Description

An antibiotic similar to flucloxacillin used in resistant staphylococci infections.

Indications

Used in the treatment of resistant staphylococci infections.

Pharmacodynamics

Oxacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms.

The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins.

Oxacillin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria.

The bactericidal activity of

Oxacillin results from the inhibition of cell wall synthesis and is mediated through Oxacillin binding to penicillin binding proteins (PBPs).

Oxacillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.

Mechanism of Action

serine-type D-Ala-D-Ala carboxypeptidase (Streptococcus pneumoniae) Inhibitor Penicillin-binding protein 2a (Streptococcus pneumoniae (strain ATCC BAA-255 / R6)) Inhibitor Penicillin-binding protein 1A (Streptococcus pneumoniae (strain ATCC BAA-255 / R6)) Inhibitor + 6 more targets.

Route of Elimination

Sodium is rapidly excreted as unchanged drug in the urine by glomerular filtration and active tubular secretion.

Adverse Effects

Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.

Alternatives